TITLE

Diet 'wonder drug' approved

AUTHOR(S)
O'Driscoll, Cath
PUB. DATE
July 2006
SOURCE
ICIS Chemical Business;7/10/2006, Vol. 1 Issue 27, p31
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that the weight-loss drug Acomplia (rimonabant) from Sanofi-Aventis has been approved for use in all 25 European Union member states. The first in a class of drugs called CB1 blockers, the pill has been licensed for use as an adjunct to diet for obese or overweight patients with complicating risk factors such as type II diabetes and heart disease.
ACCESSION #
22735920

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics